Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Albemarle

Looking At Albemarle's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Albemarle. Looking at options history for Albemarle (NYSE:ALB) we detected 10 strange trades.

Benzinga

14 Analysts Have This to Say About Albemarle

Within the last quarter, Albemarle (NYSE:ALB) has observed the following analyst ratings:

Benzinga

Here's How Much You Would Have Made Owning Albemarle Stock In The Last 10 Years

Albemarle (NYSE:ALB) has outperformed the market over the past 10 years by 3.09% on an annualized basis producing an average annual return of 14.38%. Currently, Albemarle has a market capitalization of $25.99 billion.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What Are Whales Doing With Albemarle

Someone with a lot of money to spend has taken a bullish stance on Albemarle (NYSE:ALB). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today

Albemarle (NYSE:ALB) has outperformed the market over the past 20 years by 7.66% on an annualized basis producing an average annual return of 14.78%. Currently, Albemarle has a market capitalization of $29.73 billion.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2022

Benzinga

If You Invested $1000 In Albemarle 10 Years Ago, Here's How Much You Would Have Today

Albemarle (NYSE:ALB) has outperformed the market over the past 10 years by 3.44% on an annualized basis producing an average annual return of 15.72%. Currently, Albemarle has a market capitalization of $29.99 billion.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

12 Analysts Have This to Say About Albemarle

Over the past 3 months, 12 analysts have published their opinion on Albemarle (NYSE:ALB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Albemarle Bunbury lithium facility facing workplace safety investigation after complaints

The workplace has been described by a union as a "21st century facility with a 19th century workplace safety culture", but the facility's majority owner says safety is the company's top priority.

ABC News

Why Albemarle Stock Is Rising After Hours

Albemarle Corp (NYSE: ALB) shares are trading higher in Monday's after-hours session after the company

Benzinga

Albemarle lithium processing plant just weeks from first production already looking to expand

As lithium prices surge, US chemicals company Albemarle is considering a major expansion of its refinery south of Perth, with plans for a 1,000-bed capacity workers' village at Binningup.

ABC News

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2022

Benzinga

The Best Lithium Stocks to Buy Now

Lithium is essential for powering smartphones, laptops and EVs. There's strong demand but short supply right now. Here are the best lithium stocks to buy.

Kiplinger

7 Analysts Have This to Say About Albemarle

Albemarle (NYSE:ALB) has observed the following analyst ratings within the last quarter:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Albemarle Shares Are Surging After Hours: Here's Why

Albemarle Corp (NYSE: ALB) shares are trading higher in Wednesday's after-hours session after

Benzinga

Recap: Albemarle Q1 Earnings

Albemarle (NYSE:ALB) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings Albemarle beat estimated earnings by 46.01%, reporting an EPS of $2.38 versus an estimate of $1.63.

Benzinga

$1000 Invested In Albemarle 15 Years Ago Would Be Worth This Much

Albemarle (NYSE:ALB) has outperformed the market over the past 15 years by 4.34% on an annualized basis producing an average annual return of 11.38%. Currently, Albemarle has a market capitalization of $24.34 billion.

Benzinga

Looking At Albemarle's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on Albemarle. Looking at options history for Albemarle (NYSE:ALB) we detected 28 strange trades.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

$100 Invested In Albemarle 20 Years Ago Would Be Worth This Much

Albemarle (NYSE:ALB) has outperformed the market over the past 20 years by 7.04% on an annualized basis producing an average annual return of 14.43%. Currently, Albemarle has a market capitalization of $25.70 billion.

Benzinga

If You Invested $1000 In Albemarle 20 Years Ago, Here's How Much You Would Have Today

Albemarle (NYSE:ALB) has outperformed the market over the past 20 years by 7.44% on an annualized basis producing an average annual return of 14.75%. Currently, Albemarle has a market capitalization of $25.86 billion.

Benzinga

$1000 Invested In Albemarle 15 Years Ago Would Be Worth This Much

Albemarle (NYSE:ALB) has outperformed the market over the past 15 years by 3.23% on an annualized basis.

Benzinga

A Bearish Sign Appears On Albemarle's Chart

If history is any guide, there may be trouble ahead for shares of Albemarle (NYSE:ALB). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Kiplinger

Grow With These Green ETFs and Mutual Funds

Environmental themes like renewable energy, electric vehicles and battery storage can be more enticing when pooled in funds.

Benzinga

Insiders Buy More Than $170M Of 4 Stocks

Although U.S. stock futures traded lower this morning after rising tensions between Russia and Ukraine, there were a few notable insider trades.

Benzinga

Where Albemarle Stands With Analysts

Albemarle (NYSE:ALB) has observed the following analyst ratings within the last quarter:

1 2 3 4 5

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.